Clinical trial
Vibrotactile Coordinated Reset: A Treatment for Early Stage Parkinson's Disease
NCT05545826 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vibrotactile Coordinated Reset: A Treatment for Early Stage Parkinson's Disease
- Lead sponsor
- Stanford University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- April 1, 2025
- Completion date
- October 20, 2027
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.